{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiefdyrcc7d7khrlxjlpaqcz5lkpp5osinlf5mv5hxjueke55vyxm4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mem7xoy4rrk2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigqnjevdw623pn2dfel7etpn5uvob2rxbrdnr2wxqyvpcox2ttgai"
    },
    "mimeType": "image/jpeg",
    "size": 269883
  },
  "path": "/news/2026-02-human-mesenchymal-stem-cells-neonatal.html",
  "publishedAt": "2026-02-11T12:54:32.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Neuroscience"
  ],
  "textContent": "Every year, around 15 million babies worldwide are born before 37 weeks of gestation. Being born preterm can disrupt development, and earlier births increase the risk of life-changing health outcomes. There are currently no treatment options for brain injury that occurs because of preterm birth, but progress has been made thanks to the PREMSTEM project.",
  "title": "Human mesenchymal stem cells show promise in treating neonatal brain damage, paving way for stem cell trials"
}